Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

1.6K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

351
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
351
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

642
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
642
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

310
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
310
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

425
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
425
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

STE20-type kinase TAOK3 regulates hepatic lipid partitioning.

Molecular metabolism·2021
Same author

Author Correction: Adipose expression of CREB3L3 modulates body weight during obesity.

Scientific reports·2021
Same author

Leptin counteracts hypothermia in hypothyroidism through its pyrexic effects and by stabilizing serum thyroid hormone levels.

Molecular metabolism·2021
Same author

Multiomics reveal unique signatures of human epiploic adipose tissue related to systemic insulin resistance.

Gut·2021
Same author

Adipose expression of CREB3L3 modulates body weight during obesity.

Scientific reports·2021
Same author

The Emerging Plasticizer Alternative DINCH and Its Metabolite MINCH Induce Oxidative Stress and Enhance Inflammatory Responses in Human THP-1 Macrophages.

Cells·2021

Related Experiment Video

Updated: Apr 18, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K

[Conservative obesity treatment - when and how?].

Matthias Blüher1

  • 1Klinik und Poliklinik für Endokrinologie und Nephrologie, Medizinisches Forschungszentrum Leipzig.

Deutsche Medizinische Wochenschrift (1946)
|January 13, 2015
PubMed
Summary

Obesity affects 24% of Germans and increases risks for diabetes and heart disease. Effective treatment involves diet, exercise, and behavioral changes, with surgery as a last resort for significant weight loss and improved health.

More Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.9K
A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

1.5K

Related Experiment Videos

Last Updated: Apr 18, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K
An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.9K
A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

1.5K

Area of Science:

  • Public Health
  • Metabolic Disorders
  • Cardiovascular Health

Background:

  • Obesity is a prevalent disease in Germany, affecting 24% of the population.
  • It significantly elevates the risk of developing type 2 diabetes, cardiovascular, orthopaedic, and psychological disorders.
  • Effective prevention and treatment strategies are crucial for managing obesity and its associated health risks.

Purpose of the Study:

  • To outline the current approaches for obesity treatment in Germany.
  • To detail the indications, goals, and stepwise treatment strategies for obesity management.
  • To compare the efficacy of conservative and surgical interventions for obesity.

Main Methods:

  • Review of conservative treatment strategies including diet, physical activity, and behavioral modification.
  • Evaluation of intensified conservative approaches such as very low-calorie diets, pharmacotherapy, and endoscopic therapies.
  • Analysis of surgical interventions as a treatment option for obesity.

Main Results:

  • Conservative treatment, including a 500 kcal daily deficit diet and increased physical activity, is the primary recommendation.
  • Stepwise intensification with very low-calorie diets, pharmacotherapy, or endoscopic procedures is indicated if initial targets are not met.
  • Surgical interventions demonstrate superior effectiveness in weight reduction, comorbidity improvement, and long-term weight maintenance compared to conservative methods.

Conclusions:

  • A multimodal, stepwise approach to obesity treatment is recommended, starting with conservative measures.
  • Surgical interventions are highly effective for significant weight loss and managing obesity-related comorbidities.
  • Comprehensive obesity management is essential for reducing mortality and improving overall health outcomes.